Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Good

Showing results (81-90 of 215) with videos related to

Pageof 22
Sort By:
The Journal of Infectious Diseases|July 11, 2006
Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonizationMichael R Batzloff, Jon Hartas, Weiguang Zeng, et al.
Autoimmunity Reviews|December 17, 2020
Rheumatic heart disease: A review of the current status of global research activityLeanne M Dooley, Tarek B Ahmad, Manisha Pandey, et al.
Infection and Immunity|October 16, 2002
Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1Jiraprapa Wipasa, Huji Xu, Morris Makobongo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malariaJiraprapa Wipasa, Chakrit Hirunpetcharat, Yuvadee Mahakunkijcharoen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2013
Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell helpManisha Pandey, Michelle N Wykes, Jon Hartas, et al.
Mbio|February 25, 2025
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart diseaseRukshan Ahamed Mohamed Rafeek, Natkunam Ketheesan, Michael F Good, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell functionMichelle N Wykes, Xue Q Liu, Suhua Jiang, et al.
Journal of Medicinal Chemistry|October 13, 2006
Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluationPeter M Moyle, Colleen Olive, Mei-Fong Ho, et al.
Infection and Immunity|November 19, 2008
Effect of Plasmodium yoelii exposure on vaccination with the 19-kilodalton carboxyl terminus of merozoite surface protein 1 and vice versa and implications for the application of a human malaria vaccineJiraprapa Wipasa, Huji Xu, Xueqin Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2016
The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to MalariaMarcela Montes de Oca, Michael F Good, James S McCarthy, et al.
Pageof 22

Showing results (81-90 of 215) with videos related to

Sort By:
Pageof 22
The Journal of Infectious Diseases|July 11, 2006
Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonizationMichael R Batzloff, Jon Hartas, Weiguang Zeng, et al.
Autoimmunity Reviews|December 17, 2020
Rheumatic heart disease: A review of the current status of global research activityLeanne M Dooley, Tarek B Ahmad, Manisha Pandey, et al.
Infection and Immunity|October 16, 2002
Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1Jiraprapa Wipasa, Huji Xu, Morris Makobongo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malariaJiraprapa Wipasa, Chakrit Hirunpetcharat, Yuvadee Mahakunkijcharoen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2013
Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell helpManisha Pandey, Michelle N Wykes, Jon Hartas, et al.
Mbio|February 25, 2025
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart diseaseRukshan Ahamed Mohamed Rafeek, Natkunam Ketheesan, Michael F Good, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell functionMichelle N Wykes, Xue Q Liu, Suhua Jiang, et al.
Journal of Medicinal Chemistry|October 13, 2006
Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluationPeter M Moyle, Colleen Olive, Mei-Fong Ho, et al.
Infection and Immunity|November 19, 2008
Effect of Plasmodium yoelii exposure on vaccination with the 19-kilodalton carboxyl terminus of merozoite surface protein 1 and vice versa and implications for the application of a human malaria vaccineJiraprapa Wipasa, Huji Xu, Xueqin Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2016
The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to MalariaMarcela Montes de Oca, Michael F Good, James S McCarthy, et al.
Pageof 22